Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
- 1 September 1999
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 354 (9184) , 1112-1115
- https://doi.org/10.1016/s0140-6736(99)06102-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Adverse effects of reverse transcriptase inhibitorsAIDS, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Single large-scale mitochondrial DNA deletion in a patient with mitochondrial myopathy associated with multiple symmetric lipomatosisNeurology, 1996
- Multiple symmetric lipomatosisNeurology, 1994
- Clinical features associated with the A → G transition at nucleotide 8344 of mtDNA (“MERRF mutation”)Neurology, 1993
- Mitochondrial dysfunction in multiple symmetrical lipomatosisAnnals of Neurology, 1991
- Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathyThe Lancet, 1991
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- Multiple Symmetric LipomatosisMedicine, 1984
- Multiple symmetric lipomatosis: a defect in adrenergic-stimulated lipolysis.Journal of Clinical Investigation, 1977